ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,074, issued on Aug. 25, was assigned to United Arab Emirates University (Al Ain, United Arab Emirates).
"Recombinant retroviral vectors for gene therapy" was invented by Farah Mustafa (Al Ain, United Arab Emirates), Tahir A. Rizvi (Al Ain, United Arab Emirates), Shaima Akhlaq (Al Ain, United Arab Emirates), Soumeya Jaballah (Al Ain, United Arab Emirates) and Waqar Ahmad (Al Ain, United Arab Emirates).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to Split-Intron Final Self-Inactivating (SIN) retroviral vectors which comprises a viral major splice donor (mSD) comprising mutations, a mouse mammary tumor vector long termina...